Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics. (2015)
Attributed to:
Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10928-015-9430-4
PubMed Identifier: 26231433
Publication URI: http://europepmc.org/abstract/MED/26231433
Type: Journal Article/Review
Volume: 42
Parent Publication: Journal of pharmacokinetics and pharmacodynamics
Issue: 6
ISSN: 1567-567X